198 related articles for article (PubMed ID: 19519336)
1. Recent developments of targeted therapies in the treatment of non-small cell lung cancer.
Rossi A; Maione P; Colantuoni G; Ferrara C; Rossi E; Guerriero C; Nicolella D; Falanga M; Palazzolo G; Gridelli C
Curr Drug Discov Technol; 2009 Jun; 6(2):91-102. PubMed ID: 19519336
[TBL] [Abstract][Full Text] [Related]
2. Emerging data with antiangiogenic therapies in early and advanced non-small-cell lung cancer.
Horn L; Sandler AB
Clin Lung Cancer; 2009 Mar; 10 Suppl 1(Suppl 1):S7-16. PubMed ID: 19362948
[TBL] [Abstract][Full Text] [Related]
3. The role of anti-angiogenesis in non-small-cell lung cancer: an update.
Villaruz LC; Socinski MA
Curr Oncol Rep; 2015 Jun; 17(6):26. PubMed ID: 25947099
[TBL] [Abstract][Full Text] [Related]
4. Targeting angiogenesis with multitargeted tyrosine kinase inhibitors in the treatment of non-small cell lung cancer.
Scagliotti G; Govindan R
Oncologist; 2010; 15(5):436-46. PubMed ID: 20427383
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiogenesis in the treatment of non-small cell lung cancer.
Keedy VL; Sandler AB
Cancer Sci; 2007 Dec; 98(12):1825-30. PubMed ID: 17892508
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor inhibitors and antiangiogenic agents for the treatment of non-small cell lung cancer.
Horn L; Sandler A
Clin Cancer Res; 2009 Aug; 15(16):5040-8. PubMed ID: 19671872
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapies for non-small cell lung cancer: an evolving landscape.
Pal SK; Figlin RA; Reckamp K
Mol Cancer Ther; 2010 Jul; 9(7):1931-44. PubMed ID: 20571071
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic agents in combination with chemotherapy in patients with advanced non-small cell lung cancer.
Ulahannan SV; Brahmer JR
Cancer Invest; 2011 May; 29(4):325-37. PubMed ID: 21469981
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced non small cell lung cancer.
Bareschino MA; Schettino C; Rossi A; Maione P; Sacco PC; Zeppa R; Gridelli C
J Thorac Dis; 2011 Jun; 3(2):122-33. PubMed ID: 22263075
[TBL] [Abstract][Full Text] [Related]
10. The adaptive stroma joining the antiangiogenic resistance front.
Casanovas O
J Clin Invest; 2011 Apr; 121(4):1244-7. PubMed ID: 21436579
[TBL] [Abstract][Full Text] [Related]
11. Novel Tyrosine Kinase Targets in Urothelial Carcinoma.
Torres-Jiménez J; Albarrán-Fernández V; Pozas J; Román-Gil MS; Esteban-Villarrubia J; Carrato A; Rosero A; Grande E; Alonso-Gordoa T; Molina-Cerrillo J
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451055
[TBL] [Abstract][Full Text] [Related]
12. Exploiting novel molecular targets in gastrointestinal cancers.
Ma WW; Hidalgo M
World J Gastroenterol; 2007 Nov; 13(44):5845-56. PubMed ID: 17990350
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis inhibition in lung cancer: emerging novel strategies.
Lazzari C; Bulotta A; Damiano G; Mirabile A; Viganó M; Veronesi G; Gregorc V
Curr Opin Oncol; 2022 Jan; 34(1):107-114. PubMed ID: 34812193
[TBL] [Abstract][Full Text] [Related]
14. [Advances in the targeted treatment of non-small cell lung cancer].
Ruge L; John F; Scharpenseel H; Wolf J
Inn Med (Heidelb); 2024 Mar; 65(3):211-219. PubMed ID: 38329515
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of angiogenesis and angiogenic growth factors in nonsmall cell lung cancer.
Salgia R
Cancer; 2011 Sep; 117(17):3889-99. PubMed ID: 21858799
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of angiogenesis in non-small cell lung cancer, and therapeutics targeting related molecules.
Yano S; Nishioka Y; Goto H; Sone S
Cancer Sci; 2003 Jun; 94(6):479-85. PubMed ID: 12824870
[TBL] [Abstract][Full Text] [Related]
17. ZD6474--a novel inhibitor of VEGFR and EGFR tyrosine kinase activity.
Ryan AJ; Wedge SR
Br J Cancer; 2005 Jun; 92 Suppl 1(Suppl 1):S6-13. PubMed ID: 15928657
[TBL] [Abstract][Full Text] [Related]
18. New ADCs bring new questions in EGFR NSCLC and beyond.
Scott S; Levy B
Ann Oncol; 2024 May; 35(5):412-413. PubMed ID: 38484972
[No Abstract] [Full Text] [Related]
19. Angiogenesis inhibitors in the treatment of non-small cell lung cancer.
Lind JS; Smit EF
Ther Adv Med Oncol; 2009 Sep; 1(2):95-107. PubMed ID: 21789115
[TBL] [Abstract][Full Text] [Related]
20. New molecular targeted therapies for advanced non-small-cell lung cancer.
Méndez M; Custodio A; Provencio M
J Thorac Dis; 2011 Mar; 3(1):30-56. PubMed ID: 22263060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
